Evidence map›Paper›PMID 26280273›Full record

ReviewCurrent cardiology reports2015

Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.

Taisei Kobayashi, Sahil A Parikh, Jay Giri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current cardiology reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. How To Assess a Claudication and When To Intervene.Current cardiology reports · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Taisei KobayashiCardiovascular Medicine Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Sahil A Parikh
Jay Giri
University of Pennsylvania · USUniversity School · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral artery disease (PAD) is ubiquitous in the USA and is associated with a high burden of morbidity and mortality. Clinical manifestations of PAD are broad and range from the asymptomatic patient to intermittent claudication (IC) to critical limb ischemia (CLI). The efficacy of non-invasive treatment strategies for PAD has been well documented. These include smoking cessation, supervised exercise programs, and medical therapy. Strategies for invasive management of PAD are more controversial due to variability in the manifestations of PAD including lesion length, location, severity, and clinical presentation. This has made formal comparative effectiveness of interventional therapies in PAD challenging. The current review aims to summarize the most recent clinical research in the field of PAD in patients with IC, with a focus on the latest studies regarding risk factor modification and endovascular revascularization therapies.

Indexed as

ExerciseRisk Reduction BehaviorSmoking CessationHumansHypolipidemic AgentsIntermittent ClaudicationPeripheral Vascular DiseasesPlatelet Aggregation InhibitorsPractice Guidelines as TopicRisk FactorsUnited StatesHypolipidemic AgentsPlatelet Aggregation Inhibitors

Identifiers

PMID26280273
OpenAlexW1204105486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.